I spoke to my diabetes team in B&NES yesterday.
They say that although the Libre is approved at a high level in the NHS, it is not approved by the local management yet. In fact, they were initially told that it would not be approved but that has got back for a rethink.
The expectation is it will be approved for people with high Hb1AC (but only type 1) for the first year. Then, when improvements are seen, they expect this may be relaxed. Hopefully, Abbot will have sorted out their distribution by then.
My diabetes team did not seem to be happy with this approach but did not have much control over the accountants.
I guess it is a case if making decisions where to spend money and, reading posts on the forum, pumps seem to be more readily given here than other areas.